Type 2 Diabetes Mellitus
Showing 1 - 25 of 1,595
Type 2 Diabetes, Multiple Dose Insulin Therapy Trial (Personalized treatment)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Multiple Dose Insulin Therapy
- Personalized treatment
- (no location specified)
Nov 18, 2023
Type 2 Diabetes Trial in Seoul (SGLT2 inhibitor)
Not yet recruiting
- Type 2 Diabetes Mellitus
- SGLT2 inhibitor
-
Seoul, Seodaemun-gu, Korea, Republic ofSeverance Hospital
Nov 17, 2023
Type 2 Diabetes Trial (Acetaminophen/SHR20004, Acetaminophen/Placebo)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Acetaminophen/SHR20004
- Acetaminophen/Placebo
- (no location specified)
Nov 17, 2023
Healthy, Type 2 Diabetes Trial in United States (LY3938577, Placebo, Insulin degludec)
Not yet recruiting
- Healthy
- Type 2 Diabetes Mellitus
- LY3938577
- +2 more
-
Anaheim, California
- +3 more
Nov 10, 2023
Harmonizing RCT-Duplicate Emulations In A Real World Replication
Completed
- Type 2 Diabetes Mellitus
- Canagliflozin
- +4 more
-
Gothenburg, SwedenResearch Site
Oct 23, 2023
Type 2 Diabetes, Mild Cognitive Impairment Trial in Nanjing (Henagliflozin, Gliclazide)
Recruiting
- Type 2 Diabetes Mellitus
- Mild Cognitive Impairment
-
Nanjing, Jiangsu, ChinaDivision of Endocrinology, the Affiliated Drum Tower Hospital of
Oct 10, 2023
Type 2 Diabetes, Lipid Metabolism Disorder, Fatty Acid Metabolism Disorder Trial in Lianshui (omega-3 polyunsaturated fatty
Completed
- Type 2 Diabetes Mellitus
- +2 more
- omega-3 polyunsaturated fatty acids
- corn oil
-
Lianshui, Jiangsu, ChinaLian Shui People's Hospital
Oct 2, 2023
Type 2 Diabetes Trial in Worldwide (Cagrilintide, Semaglutide, Placebo cagrilintide)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Cagrilintide
- +3 more
-
Birmingham, Alabama
- +331 more
Sep 26, 2023
Type 2 Diabetes Trial in Beijing (HSK7653 10 mg, HSK7653 25 mg, HSK7653 50 mg)
Completed
- Type 2 Diabetes Mellitus
- HSK7653 10 mg
- +3 more
-
Beijing, Beijing, ChinaPeking university people's hospital
Sep 23, 2023
Type 2 Diabetes, Hypertension Trial in Lexington (Fresh Funds)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Hypertension
- Fresh Funds
-
Lexington, KentuckyUniversity of Kentucky
Sep 5, 2023
Type 2 Diabetes, Hypertension Trial in Ibadan (Educational intervention)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Hypertension
- Educational intervention
-
Ibadan, Oyo, NigeriaDepartment of Clinical Pharmacy and Pharmacy Administration, Fac
Aug 14, 2023
Remission WithVery Low-calorie Ketogenic Diet and Lifestyle
Recruiting
- Type 2 Diabetes Mellitus
- Overweight and Obesity
- VLCKD
-
Lausanne, SwitzerlandDr. Daniela Sofra
Aug 2, 2023
Gestational Diabetes in Pregnancy, Type 2 Diabetes Trial in Lexington, Louisville (Fresh Funds for Mom's, Standard Medical care,
Not yet recruiting
- Gestational Diabetes Mellitus in Pregnancy
- Type 2 Diabetes Mellitus
- Fresh Funds for Mom's
- +2 more
-
Lexington, Kentucky
- +1 more
Jul 28, 2023
A Study of Glycemic Control in Left Ventricular Assist
Not yet recruiting
- Type 2 Diabetes Mellitus
- +2 more
- Freestyle Libre 3 Continuous Glucose Monitor (CGM)
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 28, 2023
Type 2 Diabetes, Gaming, Motivational Interviewing Trial in Bingöl (Patient Education with Game-Based Mobile Technology and
Completed
- Type 2 Diabetes Mellitus
- +5 more
- Patient Education with Game-Based Mobile Technology and Motivational Interviewing
-
Bingöl, Centrer, TurkeyBingol State Hospital
Jun 24, 2023
Type 2 Diabetes Trial in Hortolândia (LID104, Dapagliflozin, Linagliptin)
Not yet recruiting
- Type 2 Diabetes Mellitus
- LID104
- +2 more
-
Hortolândia, SP, BrazilInvestigational site
May 23, 2023
Rate and Risk Signature in Semirural Sub-Saharan Africa
Not yet recruiting
- Chronic Kidney Diseases
- +6 more
-
Bagamoyo, Pwani, TanzaniaBagamoyo District Hospital
May 19, 2023
The Impact of Frailty in Type 2 Diabetes
Enrolling by invitation
- Type 2 Diabetes Mellitus
- arms
-
Kırıkkale, Merkez, TurkeyGulsah Turanoglu
May 8, 2023
Type 1 Diabetes, Type 2 Diabetes, Hyperglycemia Trial in Winston-Salem (Libre 2.0 CGM in patients taking subcutaneous insulin
Not yet recruiting
- Type 1 Diabetes Mellitus
- +2 more
- Libre 2.0 CGM in patients taking subcutaneous insulin with concomitant high dose glucocorticoids
-
Winston-Salem, North CarolinaWakeForest University Health Sciences
May 11, 2023
Type 2 Diabetes Trial in Nanjing (Mulberry Twig Alkaloid Tablet, Canagliflozin)
Active, not recruiting
- Type 2 Diabetes Mellitus
- Mulberry Twig Alkaloid Tablet
- Canagliflozin
-
Nanjing, ChinaJianhua Ma
May 3, 2023
Type 2 Diabetes Trial (Food-related inhibitory control training based on computer, Non-food-related inhibitory control training
Not yet recruiting
- Type 2 Diabetes Mellitus
- Food-related inhibitory control training based on computer
- Non-food-related inhibitory control training based on computer
- (no location specified)
Apr 22, 2023
Type 2 Diabetes Trial in Seoul (Treatment Period(JW0201), Treatment Period(Placebo), Extension Period(JW0201))
Recruiting
- Type 2 Diabetes Mellitus
- Treatment Period(JW0201)
- +2 more
-
Seoul, Korea, Republic ofKangbuk Samsung Hospital
Apr 3, 2023
Type 2 Diabetes Trial in Gwangju (JW0201, Placebo)
Recruiting
- Type 2 Diabetes Mellitus
- JW0201
- Placebo
-
Gwangju, Korea, Republic ofChosun University Hospital
Apr 3, 2023
Oral Health Policy for Type 2 Diabetes Mellitus in Chile: A
Enrolling by invitation
- Type 2 Diabetes Mellitus
- +3 more
- Periodontal treatment
-
Puerto Varas, De Los Rios, Chile
- +1 more
Apr 11, 2023